Literature DB >> 218447

Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.

D D Gladman, M B Urowitz, E C Keystone.   

Abstract

The significance of abnormal serologic tests in systemic lupus erythematosus (SLE) in the absence of active clinical disease is unclear. In this report we describe a group of 14 patients with SLE in whom a discordance between clinical and serologic features was apparent. These patients had persistently positive lupus erythematosus preparations and antinuclear antibody tests, low serum complement levels and high levels of DNA binding. Their lymphocyte response to concanavalin A (Con A) mitogen was suppressed. They have been asymptomatic and have remained untreated for a mean of four and a quarter years.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218447     DOI: 10.1016/0002-9343(79)90529-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

Review 3.  Anti-DNA antibodies as early predictor for disease exacerbations in SLE. Guideline for treatment?

Authors:  P E Spronk; H Bootsma; C G Kallenberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  The many faces of lupus.

Authors:  H El-Gabalawy
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

Review 5.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

6.  The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.

Authors:  S Sato; X K Zhang
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.

Authors:  Michele M Tana; Zakera Shums; Jay Milo; Gary L Norman; Patrick S Leung; M Eric Gershwin; Mazen Noureddin; David E Kleiner; Xiongce Zhao; Theo Heller; Jay H Hoofnagle
Journal:  Am J Clin Pathol       Date:  2015-10       Impact factor: 2.493

8.  [The Crithidia luciliae immunofluorescence test for detection of antibodies to double-stranded DNA (author's transl)].

Authors:  P Herzer; G Greif; E M Lemmel
Journal:  Klin Wochenschr       Date:  1982-02-01

9.  Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.

Authors:  M Hebbar; P Jeannin; G Magistrelli; P-Y Hatron; E Hachulla; B Devulder; J-Y Bonnefoy; Y Delneste
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.

Authors:  E H Garin; J W Sleasman; G A Richard; A A Iravani; R S Fennell
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.